The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INTASYL self-delivering RNAi therapy specifically dual-targeting BRD4 and PD-1 to elicit complete tumor responses and evidence of synergy in a subcutaneous Hepa1-6 model of murine hepatoma in C57BL/6N mice.
 
Benjamin Cuiffo
Employment - Phio Pharmaceuticals
Patents, Royalties, Other Intellectual Property - 2013 Co-inventor with Ruibao Ren, Brandeis University, Cancer Therapy #20130210890 2014 Co-inventor with Antoine Karnoub, BIDMC/HMS, Methods and Compositions For Use In Treatment FOXP2-Related Cancers. Application#61/975,207
 
Melissa Maxwell
No Relationships to Disclose
 
Dingxue Yan
Employment - Phio Pharmaceuticals
 
Brianna Rivest
Employment - Phio Pharmaceuticals
 
James Cardia
Employment - Phio Pharmaceuticals
Stock and Other Ownership Interests - Phio Pharmaceuticals
Travel, Accommodations, Expenses - Phio Pharmaceuticals
 
Simon P Fricker
Employment - Phio Pharmaceuticals
Stock and Other Ownership Interests - Phio Pharmaceuticals
Consulting or Advisory Role - X4 Pharma